Zentalis Pharmaceuticals
ZNTL
#9381
Rank
A$0.20 B
Marketcap
A$2.05
Share price
0.00%
Change (1 day)
-0.97%
Change (1 year)

EPS for Zentalis Pharmaceuticals (ZNTL)

EPS in 2026 (TTM): A-$2.70

According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$2.76. In 2021 the company made an earnings per share (EPS) of A-$5.71 a decrease over its 2020 EPS that were of A-$4.82.

EPS history for Zentalis Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.70
2021A-$5.7118.48%
2020A-$4.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.29-89.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.44-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA